In recent years, our district has actively deepened school-enterprise cooperation, accelerating the deep integration of the talent chain with the industrial chain and innovation chain. The annual 710-ton thiophene series and prasugrel pharmaceutical intermediate production project of Shanxi Wanxinyuan Technology Co., Ltd. is yet another school-enterprise cooperation project implemented in the district. Since its groundbreaking in April this year, the project has been advancing at a rapid pace to

In recent years, our district has actively deepened school-enterprise cooperation, playing an important role in promoting the integration of the talent chain, industrial chain, and innovation chain. As another implemented school-enterprise cooperation project in our district, Shanxi Wanxinyuan Technology Co., Ltd.’s annual production project of 710 tons of thiophene series products and prasugrel pharmaceutical intermediates has been progressing intensively since construction began in April, ensu

Recently, Shanxi Wanxinyuan Technology Co., Ltd.’s annual production project of 710 tons of thiophene series products and prasugrel pharmaceutical intermediates, located in the western area of Lucheng Economic and Technological Development Zone in Changzhi City, was officially put into operation. With a total investment of 108 million yuan and covering an area of 35.69 mu, the project is a benchmark enterprise for the transformation and extension of Shanxi’s coal chemical industry toward high-en

In addition to its deep involvement in the pharmaceutical field, Shanxi Wanxinyuan Technology Co., Ltd. is actively promoting new applications of thiophenecarboxylic acid series products in the fields of functional materials and fine chemicals.

Shanxi Wanxinyuan Technology Co., Ltd. recently announced that, based on its technological accumulation in thiophene series products, the company is actively expanding into a new R&D direction for antitumor drug intermediates.

Shanxi Wanxinyuan Technology Co., Ltd.’s independently developed and produced thiophenecarboxylic acid, acetylthiophene, and prasugrel series products have recently obtained procurement certification and high recognition from several well-known domestic pharmaceutical companies.